New SEC Form D filing

Q-Immune, Inc., 2026-09-28

A new SEC Form D private-offering notice from Seattle, WA, a $1,000,000 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Q-Immune, Inc. site↗ Verified via SEC Form D

Develops a proteomic and computational platform that predicts CAR T cell therapy safety and efficacy, including cytokine release syndrome risk.

Filed 4 days agoFiled to raise $1,000,000First money in 2026-09-24Raised so far $25,000HQ (as filed) Seattle, WASector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified qimmune.com↗Named in the filing 2 executives & directors
Open this row on the live feed →More new filings in Washington →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source